Skip to main content

Profiles

Alchem Laboratories

Alchem Laboratories is an American pharmaceutical research company based in Alachua, Florida.

History

On January 4, 2020, Alchem's Chief Medical Officer Robert Malone received a call from Michael Callahan informing him about the emerging SARS-CoV-2 outbreak in Wuhan, China.[1] By this time, Malone was working with the Defense Threat Reduction Agency (DTRA)'s Discovery of Medical Countermeasures Against Novel Entities (DOMANE) program, through which Malone began investigating famotidine as a possible treatment against COVID-19.[2][3] On April 14, the Biomedical Advanced Research and Development Authority (BARDA) awarded Alchem Laboratories a $20.7 million contract to conduct a clinical trial on the drug.[2:1]

Organization

Alchem is a member of the Medical CBRN Defense Consortium[4] and the Rapid Response Partnership Vehicle (RRPV) Consortium.[5]

Personnel

Name Position Notes
James Talton President and CEO[6] Nanopharmaceutics, Discovery Cure Institute, University of Florida Department of Materials Science & Engineering, Nanotherapeutics
Robert Malone Chief Medical Officer (former)[1:1] -

Partners

Alchen is partnered with:[7][8][9][10]

  • Andarix Pharmaceuticals
  • Atossa Therapeutics
  • Brickell Biotech
  • Cato Research
  • Cerenis Therapeutics
  • Discovery Cure Institute (DCI)
  • Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (ICP)
  • Eurofins
  • Flucel
  • Gemphire Therapeutics
  • IIT Research Institute (IITRI)
  • Molecular Forecaster
  • Mountain Valley MD
  • MRIGlobal
  • Nanopharmaceutics
  • National Cancer Institute (NCI)
  • National Institute of Standards and Technology (NIST)
  • Nelson Labs
  • Northwell Health
  • Oragenics
  • Pace Labs
  • Praxis Bioresearch
  • Southern Research
  • Thermo Fisher Scientific
  • TRACON Pharmaceuticals
  • UF Innovate | Accelerate @ Sid Martin Biotech
  • United States Army Medical Research Acquisition Activity (USAMRAA)
  • United States Department of Agriculture (USDA)
  • Univar Solutions

  1. Lardner, R., & Dearen, J. (2020, July 23). Pepcid as a virus remedy? Trump admin’s $21M gamble fizzled. Washington Post. http://archive.today/2022.01.05-225516/https://www.washingtonpost.com/health/trump-admin-21m-gambit-for-pepcid-as-a-covid-remedy-fizzles/2020/07/23/84ab4aa0-cd08-11ea-99b0-8426e26d203b_story.html ↩︎ ↩︎

  2. Borrell, B. (2020). New York clinical trial quietly tests heartburn remedy against coronavirus. Science. https://doi.org/10.1126/science.abc4739 ↩︎ ↩︎

  3. Halford, B. (2020, June 15). Can Pepcid treat COVID-19? Chemical & Engineering News. https://web.archive.org/web/20200711060533/https://cen.acs.org/pharmaceuticals/Pepcid-treat-COVID-19/98/i25 ↩︎

  4. Current Members. MCDC. Retrieved January 3, 2023, from http://archive.today/2023.01.03-195328/https://www.medcbrn.org/current-members/ ↩︎

  5. Current Members. Rapid Response Partnership Vehicle (RRPV). Retrieved January 19, 2025, from https://www.rrpv.org/current-members/ ↩︎

  6. Team. Alchem Laboratories Corporation. Retrieved July 12, 2023, from http://archive.today/2023.07.12-160220/https://www.alchem.com/team ↩︎

  7. Partners. Alchem Laboratories Corporation. Retrieved July 6, 2018, from http://archive.today/2018.07.06-054221/http://www.alchem.com/partners ↩︎

  8. Partners. Alchem Laboratories. Retrieved June 3, 2020, from https://web.archive.org/web/20200603050647/http://www.alchem.com/partners ↩︎

  9. Partners. Alchem Laboratories. Retrieved June 12, 2021, from https://web.archive.org/web/20210612192714/http://www.alchem.com/partners ↩︎

  10. Partners. Alchem Laboratories Corporation. Retrieved March 2, 2023, from https://web.archive.org/web/20230302203724/https://www.alchem.com/partners ↩︎